Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Carcinoma, Non-Small-Cell Lung 18Breast Neoplasms 15Pancreatic Neoplasms 13Colorectal Neoplasms 10Rectal Neoplasms 7Stomach Neoplasms 6Neoplasm Metastasis 6Lung Neoplasms 6Neoplasms 5Recurrence 4Ovarian Neoplasms 4Uterine Cervical Neoplasms 3Small Cell Lung Carcinoma 3Prostatic Neoplasms 3Lymphoma, T-Cell, Peripheral 3Leukemia, Myeloid, Acute 3Esophageal Squamous Cell Carcinoma 3Colonic Neoplasms 3Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Treatment 2Solid Tumor 2Small Cell Lung Cancer Limited Stage 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Multiple Myeloma 2Lymphoma 2Head and Neck Neoplasms 2Glioma 2Glioblastoma 2Esophageal Neoplasms 2

Interventions

Drug Therapy 2Etoposide 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Small Cell Lung Cancer Limited Stage × Drug Therapy × Clear all
NCT05651802 2023-12-19

PCI and Brain MRI Follow-up vs Brain MRI Follow-up Alone in Limited-stage SCLC Patients

Zhejiang Cancer Hospital

Phase NA Recruiting
220 enrolled
Thoracic

Small Cell Lung Cancer Limited Stage

NCT03214003 2023-06-22

TRISS

Peking University Cancer Hospital & Institute

Phase NA Completed
235 enrolled
Thoracic

Small Cell Lung Cancer Limited Stage

Data powered by HemOnc (CC BY 4.0) Colophon âš¡